Medwell Capital advises shareholders of securities commission investor alert

    




 EDMONTON, March 23, 2012 /CNW/ - Medwell Capital Corp.  today advised shareholders that the  Alberta Securities Commission (ASC) and the British Columbia Securities  Commission (BCSC) are warning investors of what appears to be a  'recovery room' scheme that is reportedly targeting Medwell Capital  shareholders. Medwell Capital advises shareholders that it does not  have any contact with the individuals involved in this scheme. 

 The alert from the securities commissions is in response to reports that  Medwell Capital shareholders in Alberta, B.C. and Ontario have been  solicited directly via phone or email by a man misrepresenting himself  and the company that employs him and offering to purchase Medwell  Capital shares from investors in exchange for shares in a different  company at a significantly higher price. In a typical recovery room  scheme once investors agree to the deal, the operators of the scheme  ask the investor to first pay a fee for the transaction or there is a  cost to exchange shares. The operators keep the fee, but do not  repurchase the shares or issue the promised replacement shares. 

 Medwell Capital recommends that shareholders who have been contacted  call the securities commission in their home province. Medwell is  cooperating with the appropriate securities commissions regarding this  matter. 

 The full text of the investor alert is available on the Alberta  Securities Commission website or by clicking the following link: http://bit.ly/GNMQvJ. 

 About Medwell Capital Corp. 

 Medwell Capital Corp. is a Canadian-based investment and advisory firm.  For further information please visit www.medwellcapital.com. 

 Neither TSX Venture Exchange nor its Regulation Services Provider (as  that term is defined in the policies of the TSX Venture Exchange)  accepts responsibility for the adequacy or accuracy of this release.   This press release may contain forward-looking statements, which  reflect the Company's current expectation regarding future events.   These forward-looking statements involve risks and uncertainties that  may cause actual results, events or developments to be materially  different from any future results, events or developments expressed or  implied by such forward-looking statements.  Such factors include, but  are not limited to, changing market conditions, the successful and  timely completion of clinical studies, the establishment of corporate  alliances, the impact of competitive products and pricing, new product  development, uncertainties related to the regulatory approval process  and other risks detailed from time to time in the Corporation's ongoing  quarterly and annual reporting.  We undertake no obligation to publicly  update or revise any forward-looking statements, whether as a result of  new information, future events or otherwise. 


   

Medwell Capital Corp.


CONTACT:  Tony HesbyMedwell Capital Corp.780-413-7152780-408-3040 FaxE-mail: [e-mail]: http://www.medwellcapital.com Ross MarshallInvestor Relations416-815-0700 ext. 238416-815-0080 FaxE-mail:[e-mail] 


    

Copyright